Icodextrin is an iso-osmotic peritoneal dialysis solution containing glucose polymers. It is used primarily for ambulatory peritoneal dialysis (CAPD) of diabetic patients and automated peritoneal dialysis (APD) for patients with end-stage renal disease. It is injected as a solution into the peritoneal cavity. The drug is absorbed via convective transport via...
Used for continuous ambulatory peritoneal dialysis (CAPD) of diabetic patients or automated peritoneal dialysis (APD) for the management of end-stage renal disease.
Peking University First Hospital, Beijing, Beijing, China
Torsby Hospital, Torsby, Sweden
Jönköping Hospital, Jönköping, Sweden
Karlstad Hospital, Karlstad, Sweden
Cliniques Universitaires Saint-Luc, Brussels, Belgium
London Health Sciences Centre, South Street Hospital, Peritoneal Dialysis Unit, London, Ontario, Canada
Martini Hospital, Groningen, Netherlands
Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong
Prince of Wales Hospital Chinese University of Hong Kong, Sha Tin, N.t., Hong Kong
Kyungpook National University Hospital, Chung-Gu, Deagu, Korea, Republic of
Yeungnam University Medical Center, Nam-gu, Deagu, Korea, Republic of
Westmead Hospital, Sydney, New South Wales, Australia
Gold Coast Hospital, South Port, Australia
University Health Network, Toronto General Hospital, Toronto, Ontario, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.